From extending lifespan to bolstering the immune system, the drug’s effects are only just beginning to be understood.
Science under Trump, gene drive, medical marijuana, and more
January 1, 2017|
© ISTOCK.COM/BASTIAAN SLABBERS
—Biologist Andrew Rosenberg, director of the Center for Science and Democracy, on the prospects for evidence-based policymaking in the Trump Administration. (The Atlantic, December 2)
— ACLU attorney Alex Abdo, speaking to The Scientist about the organization’s plans for defending the rights of scientists should the need arise during the Trump presidency (December 2)
—Ricarda Steinbrecher, a molecular geneticist representing the Federation of German Scientists, advocating for a cessation of research on using gene drive to combat mosquito-borne diseases at the recent 2016 United Nations Convention on Biodiversity meeting in Mexico (December 5)
—Ron Vale, University of California, San Francisco, cell biologist and founder of the preprint advocacy group ASAPbio, on a recently announced decision by the NIH-funded research consortium the 4D Nucleome to mandate that its awardees post their manuscripts to online preprint servers prior to peer review (November 30)
—Canadian Science Minister Kirsty Duncan, speaking in early November about the need to better represent women scientists in the Canada Research Chairs program. In December, the Canadian government announced a cohort of 203 new and renewed Canada Research Chairs that is 38 percent female, one of the largest proportions ever.
—Benjamin Han, a geriatrician at New York University’s Langone Medical Center, on his recently published Addiction study that found a 71 percent increase in marijuana use among US adults aged 50 and older from 2006 to 2013 (December 2)